Dongkook Pharmaceutical Co Ltd banner
D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 20 450 KRW -3.54% Market Closed
Market Cap: ₩925B

Dongkook Pharmaceutical Co Ltd
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Dongkook Pharmaceutical Co Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Inventory
₩178.1B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
18%
Yuhan Corp
KRX:000100
Inventory
₩337.7B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Inventory
₩104B
CAGR 3-Years
14%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Inventory
₩319.1B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
8%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Inventory
₩47.8B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
10%
C
Caregen Co Ltd
KOSDAQ:214370
Inventory
₩22.7B
CAGR 3-Years
41%
CAGR 5-Years
28%
CAGR 10-Years
N/A
No Stocks Found

Dongkook Pharmaceutical Co Ltd
Glance View

Market Cap
925B KRW
Industry
Pharmaceuticals

DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Intrinsic Value
25 422.63 KRW
Undervaluation 20%
Intrinsic Value
Price
D

See Also

What is Dongkook Pharmaceutical Co Ltd's Inventory?
Inventory
178.1B KRW

Based on the financial report for Sep 30, 2025, Dongkook Pharmaceutical Co Ltd's Inventory amounts to 178.1B KRW.

What is Dongkook Pharmaceutical Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
18%

Over the last year, the Inventory growth was 7%. The average annual Inventory growth rates for Dongkook Pharmaceutical Co Ltd have been 14% over the past three years , 16% over the past five years , and 18% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett